StockNow
Calendar
Log in
Other

US FDA has approved Novo's (NOVOB DC) once-weekly insulin treatment for paediatric patients with type 2 diabetes mellitus

StockNow breaking-news AI analysis

The supplied breaking news reports US FDA approval of Novo’s once-weekly insulin treatment for paediatric patients with type 2 diabetes mellitus.

1 stocks
NVONovo-Nordisk A/S$38.97Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Politics

US Treasury Secretary Bessent posts "... the United States is no longer managing the Iranian threat. We are ending it."

Politics

[MARKET UPDATE] Spot gold slips below USD 4k/oz, but remains just above the USD 3986/oz low. Further, modest, pressure seen in equity futures.

Geopolitics

US President Trump says "we could end the Iran war very quickly", adds "do we want to finish it or let it within is the question"; we could take all of the oil in Iran; The Strait of Hormuz is all ours